Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 2 de 2
1.
Immunopharmacology ; 49(3): 263-74, 2000 Sep.
Article En | MEDLINE | ID: mdl-10996024

The effects of intratracheal administration of anaphylatoxin C5a on airway inflammation have been studied using two sources of material, zymosan activated serum (ZAS) and purified rat C5a des Arg, in order to determine the influence of complement activation on allergic airway disorders.The intratracheal administration of ovalbumin (OA) to OA-sensitized rats generated two phases of airway response, an immediate airway response (IAR) occurring within 15 min and a late airway response (LAR) beginning 4-6 h after the allergen challenge. The simultaneous administration of ZAS and OA into the trachea generated a sustained elevation of airway resistance (Raw) following IAR, while that of OA or ZAS alone resulted in Raw returning nearly to the baseline just after the IAR. The elevation of Raw after the combined challenge of OA and ZAS was significantly inhibited by pretreatment with a CysLT(1) receptor antagonist, pranlukast 30 mg/kg, but after that OA or ZAS alone was not significantly inhibited by pranlukast. The intratracheal administration of purified C5a produced an airway response that was similar to, but higher than, that evoked by ZAS. Namely, the challenge with OA plus C5a resulted in a higher IAR than OA plus ZAS, and also caused an early animal death up to 6 h, which was prevented by a combined pretreatment with pranlukast and the H(1) receptor antagonist, diphenhydramine.A histological examination at 6 h after the OA challenge identified an infiltration of inflammatory cells into the bronchial submucosal tissue, with a predominance of neutrophils and fewer eosinophils. On the other hand, a histological examination after the OA and ZAS challenge showed more severe infiltration of granulocytes into the bronchial submucosal tissue than that with OA or ZAS alone. The challenge with OA plus C5a was associated with severe perivascular leakage in the lungs and the combined pretreatment with both the antagonists led to a marked reduction in perivascular leakage. The quantitation of N-acetyl-leukotriene E(4) (N-Ac-LTE(4)), a major metabolite of cysteinyl-leukotrienes (cysLTs), in the bile indicated a significantly greater and longer excretion of cysLTs, from 1 to 6 h after the combined challenge, than that after either OA or ZAS alone. This suggested a prolonged generation of cysLTs in the lung by the combined challenge.In conclusion, our findings suggest that anaphylatoxin C5a may mediate the airway inflammatory response induced by a specific antigen challenge partly through a prolonged production of cysLTs and the release of histamine.


Antigens/administration & dosage , Complement C5a/administration & dosage , Cysteine/biosynthesis , Inflammation Mediators/administration & dosage , Leukotriene E4/analogs & derivatives , Leukotrienes/biosynthesis , Lung/immunology , Membrane Proteins , Receptors, Leukotriene , Airway Resistance/immunology , Animals , Antigens/immunology , Bile/metabolism , Chromones/administration & dosage , Complement C5a, des-Arginine/administration & dosage , Cysteine/physiology , Diphenhydramine/administration & dosage , Histamine H1 Antagonists/administration & dosage , Hypersensitivity, Immediate/immunology , Injections, Subcutaneous , Intubation, Intratracheal , Leukotriene Antagonists , Leukotriene D4/metabolism , Leukotriene E4/metabolism , Leukotrienes/physiology , Lung/pathology , Male , Ovalbumin/administration & dosage , Ovalbumin/immunology , Rats , Rats, Inbred BN , Zymosan/administration & dosage
2.
Blood ; 86(11): 4039-49, 1995 Dec 01.
Article En | MEDLINE | ID: mdl-7492759

T-helper cells can differentiate into at least two subtypes secreting distinct profiles of cytokines, Th1 and Th2, regulating immunoprotection and different immunopathologies. Interleukin-4 (IL-4) is both the product and the inducer of Th2 cells, raising the question whether IL-4 can be produced in response to antigen-independent stimuli. Here we show that human basophils produce IL-4 on stimulation with IL-3 and C5a or C5adesarg in similar amounts as induced by IgE-receptor-cross-linking. C5a-induced IL-4 production requires the presence of IL-3, with little effect of the sequence of stimuli addition. No "Th1-cytokines" (interferon-gamma and IL-2) and even no "Th2-cytokines" (IL-3, IL-5, IL-10, and granulocyte-macrophage colony-stimulating factor) are produced by basophils in response to either IgE-dependent or IgE-independent activation. The generation of leukotriene C4 (LTC4) is regulated in a similar manner. However, C5a induces a rapid, transient burst of leukotriene formation only if added after IL-3. Interestingly, upon prolonged culture, a late phase of continuous LTC4 production is observed, which also requires two signals (IL-3 and C5a), but rather depends on their continuous presence than on their sequence of action. These data describe an antigen-independent pathway of very restricted IL-4 expression. Thus, basophils must be considered as central immunoregulatory cells of the innate immune system. Furthermore, the results show that LTC4 can also be generated more continuously for many hours, a phenomenon that may be of particular importance in chornic allergic inflammation, such as asthma.


Basophils/immunology , Basophils/metabolism , Interleukin-4/biosynthesis , Leukotriene C4/biosynthesis , Basophils/drug effects , Complement C5a/pharmacology , Complement C5a, des-Arginine/administration & dosage , Complement C5a, des-Arginine/pharmacology , Cytokines/biosynthesis , Cytokines/blood , Dose-Response Relationship, Drug , Humans , Immunoglobulin E/blood , In Vitro Techniques , Interleukin-3/pharmacology , Interleukin-4/blood , Kinetics , Leukotriene C4/blood , Signal Transduction
...